Gene editing technology for treatment-resistant cancer could be a 'scientific layup' to treat other diseases

For the first time, a new gene editing technology called base editing was used to modify immune cells and successfully treat a teen with treatment-resistant leukemia. A month afterward, 13-year-old Alyssa was in remission, and she continues to do well several months later.

Gene editing technology for treatment-resistant cancer could be a 'scientific layup' to treat other diseases

Gene Editing Reveals Potential Cancer Treatment Target

Alexa Miller on LinkedIn: CRISPR-Cas9: From Bacterial Adaptive Immune Response To Editing and…

Spellman Social on LinkedIn: Gene editing technology for treatment-resistant cancer could be a…

LabOmics on LinkedIn: Gene editing technology for treatment-resistant cancer could be a…

Buildings November 2021 - Browse Articles

Spencer Waspi on LinkedIn: Life Sciences Deals: By the Numbers

Cancers, Free Full-Text

Gene editing technology for treatment-resistant cancer could be a 'scientific layup' to treat other diseases, Health

Good Day BIO: FDA cut back on Accelerated Approvals in 2022

Gene editing technology for treatment-resistant cancer could be a 'scientific layup' to treat other diseases

In First, Scientists Use CRISPR for Personalized Cancer Treatment

Scientists develop a rapid gene-editing screen to find effects of cancer mutations, MIT News